-
1تقرير
المصدر: PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/Ib Platform Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05868226Test
-
2تقرير
المؤلفون: National Institutes of Health (NIH)
المصدر: Imaging of HER2-expressing Cancer With Site-Specifically Labeled 89Zr-ss-Pertuzumab
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04692831Test
Other URLs: http://www.mskcc.orgTest
-
3تقرير
المؤلفون: Byondis B.V.
المصدر: ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04602117Test
